Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 3261-3270 of 11598

Edit search filters
  1. A Study of Afatinib Treatment for Patients with Epidermal Growth Factor Receptor Mutation Positive Non-Small Cell Lung Cancer, Who Are Age 70 or Older

    Scottsdale/Phoenix, AZ

  2. A Study of the GORE® TAG® Thoracic Branch Endoprosthesis for Treating Proximal Descending Thoracic Aortic Aneurysms

    Rochester, MN

  3. Short Versus Long Cephalomedullary Nailing of Pertrochanteric Hip Fractures: A Randomized Prospective Study

    Rochester, MN

  4. Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus

    Rochester, MN

  5. A Study of a Sleep Health ‘App’ to Help First-Time Users of Positive Airway Pressure Therapy for Sleep Apnea

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Combination Study of SV-BR-1-GM in Combination With INCMGA00012 and Retifanlimab

    Jacksonville, FL

  7. Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies

    Rochester, MN

  8. Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma

  9. Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma

    Rochester, MN

  10. A Study Using Clofarabine and Cytarabine in Treating Children with Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

.

Mayo Clinic Footer